Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Health care spending in 2009 and 2010 grew at the slowest rate in 50 years, causing the Centers for Medicare & Medicaid services to point fingers at high unemployment rates and reduced household income.
In an exclusive interview, Medtronic (NYSE:MDT) CEO Omar Ishrak tells MassDevice.com about how he screens potential acquisitions, his plan to re-shape the company and handling the controversy over the Infuse spine treatment.